abstract |
The use of a compound selected from a range of compounds including quorum sensing molecules, N-acyl homo serine lactones, N-(3-oxododecanoyl)-L-homoserine lactone, inhibitors to modulate STAT activity for the treatment of a range of diseases including cancer, breast cancer, obesity, lipid metabolism disorders, immune disease, immune deficiency or immune disorders. The range of compounds also include compounds of formula (I) in which R is an acyl group of formula (II). |